Angiotensin AT1 Receptor Antagonists

 
Cat.No.
Product Name / Activity
4553 Azilsartan
Potent AT1 receptor inverse agonist; antihypertensive
4791 Candesartan
AT1 receptor antagonist
4792 Candesartan cilexetil
Prodrug of candesartan (Cat. No. 4791), an AT1 receptor antagonist
1849 EMD 66684
Potent, selective non-peptide AT1 antagonist
4696 Eprosartan mesylate
Potent and selective AT1 receptor antagonist
5728 EXP 3174
Potent and selective AT1 receptor antagonist
5798 Irbesartan
Potent AT1 antagonist
3798 Losartan potassium
Selective, non-peptide AT1 antagonist
4616 Olmesartan
Potent AT1 antagonist; metabolite of Olmesartan medoxomil (Cat. No. 4620)
4620 Olmesartan medoxomil
Selective non-peptide AT1 antagonist; prodrug of Olmesartan
5139 Telmisartan
AT1 antagonist; PPARγ partial agonist
4216 Valsartan
High affinity, selective AT1 antagonist
1211 ZD 7155 hydrochloride
Selective non-peptide AT1 antagonist

View all Angiotensin AT1 Receptor products

Quick Order

Find multiple products by catalog number

divider line

Cardiovascular Research Product Guide

Cardiovascular Research Product Guide

Our Cardiovascular Guide highlights over 250 products for cardiovascular research. Request copy or view PDF today.

divider line

Peptide Hormone Receptors Product Listing

Peptide Hormone Receptors Product Listing

Our Peptide Hormone Receptors Listing highlights over 200 products for peptide hormone receptors. Request copy or view PDF today.

divider line

GPCR Product Listing

GPCR Product Listing

Highlights over 450 products for GPCRs. Request copy or view PDF today.

divider line

Regulation of Vascular Reactivity by GPCRs

Written by J.J. Maguire and A.P. Davenport

Cardiovascular Life Science Poster

Our Cardiovascular poster highlights the key G protein-coupled receptors involved in the regulation of vascular reactivity. Request copy today.

divider line

Twitter Updates

Follow @Tocris on Twitter

Follow us on Twitter!

Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.